Drake & Associates’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$718K Sell
7,267
-63
-0.9% -$6.58K 0.11% 56
2026
Q2
$665K Buy
7,330
+64
+0.9% +$5.84K 0.11% 60
2026
Q1
$746K Sell
7,266
-64
-0.9% -$7.23K 0.14% 57
2025
Q4
$918K Sell
7,330
-2,870
-28% -$366K 0.18% 61
2025
Q3
$1.27M Buy
10,200
+3,711
+57% +$487K 0.27% 50
2025
Q2
$883K Sell
6,489
-181
-3% -$23.9K 0.22% 50
2025
Q1
$885K Sell
6,670
-102
-2% -$13K 0.25% 44
2024
Q4
$874K Buy
6,772
+88
+1% +$10.2K 0.25% 46
2024
Q3
$762K Buy
6,684
+154
+2% +$16.9K 0.25% 30
2024
Q2
$679K Sell
6,530
-74
-1% -$7.85K 0.24% 29
2024
Q1
$751K Sell
6,604
-100
-1% -$11.5K 0.27% 28
2023
Q4
$738K Hold
6,704
– – 0.3% 27
2023
Q3
$649K Sell
6,704
-99
-1% -$10.4K 0.29% 27
2023
Q2
$742K Sell
6,803
-50
-0.7% -$5.33K 0.33% 26
2023
Q1
$694K Buy
6,853
+122
+2% +$12.9K 0.34% 24
2022
Q4
$739K Buy
+6,731
New +$697K 0.39% 20

Other funds holding ABT

Drake & Associates's ABT Position: Q3 2026 in Review

Drake & Associates reduced its Abbott (ABT) stake by 0.86% in Q3 2026, selling an estimated $6.58K and leaving 7,267 shares worth $718K. The position accounts for 0.11% of the portfolio, ranked #56.

Drake & Associates first reported a position in ABT in Q4 2022 and has held it in 16 quarters since. The position peaked at $1.27M in Q3 2025. 3,040 funds tracked by Wall St. Rank hold ABT as of Q3 2026.

  • Drake & Associates held 7,267 shares of Abbott worth $718K as of Q3 2026.
  • Drake & Associates sold 63 Abbott shares in Q3 2026, an estimated $6.58K.
  • Abbott made up 0.11% of Drake & Associates's portfolio in Q3 2026, its #56 holding.
  • Drake & Associates first reported a position in Abbott in Q4 2022 and has held it in 16 quarters since.
  • Drake & Associates's Abbott position peaked at $1.27M in Q3 2025.
  • 3,040 funds tracked by Wall St. Rank held Abbott as of Q3 2026.

Based on Drake & Associates's 13F filing for Q3 2026, filed 18 Nov 2026.